OBSERVE: guidelines for the refinement of rodent cancer models.
Journal
Nature protocols
ISSN: 1750-2799
Titre abrégé: Nat Protoc
Pays: England
ID NLM: 101284307
Informations de publication
Date de publication:
11 Jul 2024
11 Jul 2024
Historique:
received:
28
02
2023
accepted:
23
02
2024
medline:
12
7
2024
pubmed:
12
7
2024
entrez:
11
7
2024
Statut:
aheadofprint
Résumé
Existing guidelines on the preparation (Planning Research and Experimental Procedures on Animals: Recommendations for Excellence (PREPARE)) and reporting (Animal Research: Reporting of In Vivo Experiments (ARRIVE)) of animal experiments do not provide a clear and standardized approach for refinement during in vivo cancer studies, resulting in the publication of generic methodological sections that poorly reflect the attempts made at accurately monitoring different pathologies. Compliance with the 3Rs guidelines has mainly focused on reduction and replacement; however, refinement has been harder to implement. The Oncology Best-practices: Signs, Endpoints and Refinements for in Vivo Experiments (OBSERVE) guidelines are the result of a European initiative supported by EurOPDX and INFRAFRONTIER, and aim to facilitate the refinement of studies using in vivo cancer models by offering robust and practical recommendations on approaches to research scientists and animal care staff. We listed cancer-specific clinical signs as a reference point and from there developed sets of guidelines for a wide variety of rodent models, including genetically engineered models and patient derived xenografts. In this Consensus Statement, we systematically and comprehensively address refinement and monitoring approaches during the design and execution of murine cancer studies. We elaborate on the appropriate preparation of tumor-initiating biologicals and the refinement of tumor-implantation methods. We describe the clinical signs to monitor associated with tumor growth, the appropriate follow-up of animals tailored to varying clinical signs and humane endpoints, and an overview of severity assessment in relation to clinical signs, implantation method and tumor characteristics. The guidelines provide oncology researchers clear and robust guidance for the refinement of in vivo cancer models.
Identifiants
pubmed: 38992214
doi: 10.1038/s41596-024-00998-w
pii: 10.1038/s41596-024-00998-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer Nature Limited.
Références
O’Brien, S. G. et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N. Engl. J. Med. 348, 994–1004 (2003).
pubmed: 12637609
doi: 10.1056/NEJMoa022457
Fazio, M., Ablain, J., Chuan, Y., Langenau, D. M. & Zon, L. I. Zebrafish patient avatars in cancer biology and precision cancer therapy. Nat. Rev. Cancer 20, 263–273 (2020).
pubmed: 32251397
pmcid: 8011456
doi: 10.1038/s41568-020-0252-3
Pauli, C. et al. Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discov. 7, 462–477 (2017).
pubmed: 28331002
pmcid: 5413423
doi: 10.1158/2159-8290.CD-16-1154
Le Magnen, C., Dutta, A. & Abate-Shen, C. Optimizing mouse models for precision cancer prevention. Nat. Rev. Cancer 16, 187––196 (2016).
pubmed: 26893066
pmcid: 5517771
doi: 10.1038/nrc.2016.1
Animals used for scientific purposes. European Commission https://ec.europa.eu/environment/chemicals/lab_animals/alures_en.htm (2022).
Guillen, K. P. et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat. Cancer 3, 232–250 (2022).
pubmed: 35221336
pmcid: 8882468
doi: 10.1038/s43018-022-00337-6
Honkala, A., Malhotra, S. V., Kummar, S. & Junttila, M. R. Harnessing the predictive power of preclinical models for oncology drug development. Nat. Rev. Drug Discov. 21, 99–114 (2022).
pubmed: 34702990
doi: 10.1038/s41573-021-00301-6
Cuppens, T. et al. Potential targets’ analysis reveals dual PI3K/mTOR pathway inhibition as a promising therapeutic strategy for uterine leiomyosarcomas—an ENITEC group initiative. Clin. Cancer Res. 23, 1274–1285 (2017).
pubmed: 28232476
doi: 10.1158/1078-0432.CCR-16-2149
Hebert, J. D., Neal, J. W. & Winslow, M. M. Dissecting metastasis using preclinical models and methods. Nat. Rev. Cancer 23, 391–407 (2023).
pubmed: 37138029
doi: 10.1038/s41568-023-00568-4
Perse, M. Cisplatin mouse models: treatment, toxicity and Translatability. Biomedicines 9, 1406 (2021).
pubmed: 34680523
pmcid: 8533586
doi: 10.3390/biomedicines9101406
Karkampouna, S. et al. Patient-derived xenografts and organoids model therapy response in prostate cancer. Nat. Commun. 12, 1117 (2021).
pubmed: 33602919
pmcid: 7892572
doi: 10.1038/s41467-021-21300-6
Patton, E. E. et al. Melanoma models for the next generation of therapies. Cancer Cell 39, 610–631 (2021).
pubmed: 33545064
pmcid: 8378471
doi: 10.1016/j.ccell.2021.01.011
Zitvogel, L., Pitt, J. M., Daillere, R., Smyth, M. J. & Kroemer, G. Mouse models in oncoimmunology. Nat. Rev. Cancer 16, 759–773 (2016).
pubmed: 27687979
doi: 10.1038/nrc.2016.91
Gardner, E. E. & Rudin, C. M. Drug therapy: preclinical oncology—reporting transparency needed. Nat. Rev. Clin. Oncol. 13, 8–9 (2016).
pubmed: 26667971
doi: 10.1038/nrclinonc.2015.216
Amaral, O. B. & Neves, K. Reproducibility: expect less of the scientific paper. Nature 597, 329–331 (2021).
pubmed: 34526702
doi: 10.1038/d41586-021-02486-7
Pritt, S. L. & Hammer, R. E. The interplay of ethics, animal welfare, and IACUC oversight on the reproducibility of animal studies. Comp. Med. 67, 101–105 (2017).
pubmed: 28381309
pmcid: 5402729
Cheleuitte-Nieves, C. & Lipman, N. S. Improving replicability, reproducibility, and reliability in preclinical research: a shared responsibility. ILAR J. 60, 113–119 (2019).
doi: 10.1093/ilar/ilaa009
Errington, T. M. et al. Investigating the replicability of preclinical cancer biology. eLife 10, e.71601 (2021).
doi: 10.7554/eLife.71601
Smith, A. J., Clutton, R. E., Lilley, E., Hansen, K. E. A. & Brattelid, T. PREPARE: guidelines for planning animal research and testing. Lab. Anim. 52, 135–141 (2018).
pubmed: 28771074
doi: 10.1177/0023677217724823
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).
pubmed: 20613859
pmcid: 2893951
doi: 10.1371/journal.pbio.1000412
Percie du Sert, N. et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PloS Biol. 18, e3000410 (2020).
pubmed: 32663219
pmcid: 7360023
doi: 10.1371/journal.pbio.3000410
EU Parliament event on animal research. European Animal Resarch Association https://www.eara.eu/post/eu-parliament-event-on-animal-research (2022).
Russell, W. M. S. & Burch, R. L. The Principles of Humane Experimental Technique. (Methuen, 1959).
Tannenbaum, J. & Bennett, B. T. Russell and Burch’s 3Rs then and now: the need for clarity in definition and purpose. J. Am. Assoc. Lab. Anim. Sci. 54, 120–132 (2015).
pubmed: 25836957
pmcid: 4382615
Workman, P. et al. Guidelines for the welfare and use of animals in cancer research. Br. J. Cancer 102, 1555–1577 (2010).
pubmed: 20502460
pmcid: 2883160
doi: 10.1038/sj.bjc.6605642
Wallace, J. Humane endpoints and cancer research. ILAR J. 41, 87–93 (2000).
pubmed: 11417496
doi: 10.1093/ilar.41.2.87
Workman, P. et al. UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab. Anim. 22, 195–201 (1988).
pubmed: 3172698
doi: 10.1258/002367788780746467
Winn, C. B. et al. Automated monitoring of respiratory rate as a novel humane endpoint: a refinement in mouse metastatic lung cancer models. PLoS ONE 16, e0257694 (2021).
pubmed: 34543354
pmcid: 8452061
doi: 10.1371/journal.pone.0257694
Aldred, A. J., Cha, M. C. & Meckling-Gill, K. A. Determination of a humane endpoint in the L1210 model of murine leukemia. Contemp. Top. Lab. Anim. Sci. 41, 24–27 (2002).
pubmed: 11958599
Paster, E. V., Villines, K. A. & Hickman, D. L. Endpoints for mouse abdominal tumor models: refinement of current criteria. Comp. Med. 59, 234–241 (2009).
pubmed: 19619413
pmcid: 2733284
Helgers, S. O. A. et al. Body weight algorithm predicts humane endpoint in an intracranial rat glioma model. Sci. Rep. 10, 9020 (2020).
pubmed: 32488031
pmcid: 7265476
doi: 10.1038/s41598-020-65783-7
Oliveira, M. et al. Implementation of humane endpoints in a urinary bladder carcinogenesis study in rats. Vivo 31, 1073–1080 (2017).
Silva-Reis, R. et al. Refinement of animal model of colorectal carcinogenesis through the definition of novel humane endpoints. Animals 11, 985 (2021).
pubmed: 33915847
pmcid: 8066901
doi: 10.3390/ani11040985
Akladios, C., Ignat, M., Mutter, D. & Aprahamian, M. Survival variability of controls and definition of imaging endpoints for longitudinal follow-up of pancreatic ductal adenocarcinoma in rats. J. Cancer Res. Clin. Oncol. 143, 29–34 (2017).
pubmed: 27620742
doi: 10.1007/s00432-016-2265-6
Kobaek-Larsen, M., Rud, L., Oestergaard Soerensen, F. & Ritskes-Hoitinga, J. Laparoscopy of rats with experimental liver metastases: a method to assess new humane endpoints. Lab. Anim. 38, 162–168 (2004).
pubmed: 15070456
doi: 10.1258/002367704322968849
Percie du Sert, N. et al. The IMPROVE guidelines (ischaemia models: procedural refinements of in vivo experiments). J. Cereb. Blood Flow. Metab. 37, 3488–3517 (2017).
pubmed: 28797196
pmcid: 5669349
doi: 10.1177/0271678X17709185
Mirzoyan, Z. et al. Drosophila melanogaster: a model organism to study cancer. Front. Genet. 10, 51 (2019).
pubmed: 30881374
pmcid: 6405444
doi: 10.3389/fgene.2019.00051
Yamamura, R., Ooshio, T. & Sonoshita, M. Tiny Drosophila makes giant strides in cancer research. Cancer Sci. 112, 505–514 (2021).
pubmed: 33275812
pmcid: 7893992
doi: 10.1111/cas.14747
Robertson, N., Schook, L. B. & Schachtschneider, K. M. Porcine cancer models: potential tools to enhance cancer drug trials. Expert Opin. Drug Discov. 15, 893–902 (2020).
pubmed: 32378979
doi: 10.1080/17460441.2020.1757644
Oh, J. H. & Cho, J. Y. Comparative oncology: overcoming human cancer through companion animal studies. Exp. Mol. Med. 55, 725–734 (2023).
pubmed: 37009802
pmcid: 10167357
doi: 10.1038/s12276-023-00977-3
Deycmar, S., Gomes, B., Charo, J., Ceppi, M. & Cline, J. M. Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy. J. Immunother. Cancer 11, e005514 (2023).
pubmed: 36593067
doi: 10.1136/jitc-2022-005514
Cannon, C. M. Cats, cancer and comparative oncology. Vet. Sci. 2, 111–126 (2015).
pubmed: 29061935
pmcid: 5644631
Overgaard, N. H. et al. Of mice, dogs, pigs, and men: choosing the appropriate model for immuno-oncology research. ILAR J. 59, 247–262 (2018).
pubmed: 30476148
doi: 10.1093/ilar/ily014
LeBlanc, A. K. & Mazcko, C. N. Improving human cancer therapy through the evaluation of pet dogs. Nat. Rev. Cancer 20, 727–742 (2020).
pubmed: 32934365
doi: 10.1038/s41568-020-0297-3
Schook, L. B. et al. A genetic porcine model of cancer. PLoS ONE 10, e0128864 (2015).
pubmed: 26132737
pmcid: 4488487
doi: 10.1371/journal.pone.0128864
Kalla, D. et al. The missing link: cre pigs for cancer research. Front. Oncol. 11, 755746 (2021).
pubmed: 34692545
pmcid: 8531543
doi: 10.3389/fonc.2021.755746
Kalla, D., Kind, A. & Schnieke, A. Genetically engineered pigs to study cancer. Int. J. Mol. Sci. 21, 488 (2020).
pubmed: 31940967
pmcid: 7013672
doi: 10.3390/ijms21020488
Astell, K. R. & Sieger, D. Zebrafish in vivo models of cancer and metastasis. Cold Spring Harb. Perspect. Med. 10, a037077 (2020).
pubmed: 31615862
pmcid: 7397842
doi: 10.1101/cshperspect.a037077
Jiang, H., Kimura, T., Hai, H., Yamamura, R. & Sonoshita, M. Drosophila as a toolkit to tackle cancer and its metabolism. Front. Oncol. 12, 982751 (2022).
pubmed: 36091180
pmcid: 9458318
doi: 10.3389/fonc.2022.982751
Hendricks-Wenger, A. et al. Employing novel porcine models of subcutaneous pancreatic cancer to evaluate oncological therapies. Methods Mol. Biol. 2394, 883–895 (2022).
pubmed: 35094364
doi: 10.1007/978-1-0716-1811-0_47
Callesen, M. M. et al. A genetically inducible porcine model of intestinal cancer. Mol. Oncol. 11, 1616–1629 (2017).
pubmed: 28881081
pmcid: 5664002
doi: 10.1002/1878-0261.12136
Boas, F. E. et al. Induction and characterization of pancreatic cancer in a transgenic pig model. PLoS ONE 15, e0239391 (2020).
pubmed: 32956389
pmcid: 7505440
doi: 10.1371/journal.pone.0239391
Saur, D. & Schnieke, A. Porcine cancer models for clinical translation. Nat. Rev. Cancer 22, 375–376 (2022).
pubmed: 35302113
doi: 10.1038/s41568-022-00467-0
Jarvis, S. et al. Non-rodent animal models of osteosarcoma: a review. Cancer Treat. Res. Commun. 27, 100307 (2021).
pubmed: 33453605
doi: 10.1016/j.ctarc.2021.100307
Penet, M. F. et al. Ascites volumes and the ovarian cancer microenvironment. Front. Oncol. 8, 595 (2018).
pubmed: 30619738
pmcid: 6304435
doi: 10.3389/fonc.2018.00595
Sale, S. & Orsulic, S. Models of ovarian cancer metastasis: murine models. Drug Discov. Today Dis. Models 3, 149––154 (2006).
pubmed: 19337569
pmcid: 2662599
doi: 10.1016/j.ddmod.2006.05.006
Zakarya, R., Howell, V. M. & Colvin, E. K. Modelling epithelial ovarian cancer in mice: classical and emerging approaches. Int. J. Mol. Sci. 21, 4806 (2020).
pubmed: 32645943
pmcid: 7370285
doi: 10.3390/ijms21134806
Ehlich, H. et al. INFRAFRONTIER quality principles in systemic phenotyping. Mamm., Genome 33, 120–122 (2022).
pubmed: 34328547
doi: 10.1007/s00335-021-09892-2
Meehan, T. F. et al. PDX-MI: minimal information for patient-derived tumor xenograft models. Cancer Res. 77, e62–e66 (2017).
pubmed: 29092942
pmcid: 5738926
doi: 10.1158/0008-5472.CAN-17-0582
Peterson, N. C. From bench to cageside: risk assessment for rodent pathogen contamination of cells and biologics. ILAR J. 49, 310–315 (2008).
pubmed: 18506064
doi: 10.1093/ilar.49.3.310
Nicklas, W., Kraft, V. & Meyer, B. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab. Anim. Sci. 43, 296–300 (1993).
pubmed: 8231085
Geraghty, R. J. et al. Guidelines for the use of cell lines in biomedical research. Br. J. Cancer 111, 1021–1046 (2014).
pubmed: 25117809
pmcid: 4453835
doi: 10.1038/bjc.2014.166
Chateau-Joubert, S. et al. Spontaneous mouse lymphoma in patient-derived tumor xenografts: the importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials. Transl. Oncol. 14, 101133 (2021).
pubmed: 34051622
pmcid: 8170170
doi: 10.1016/j.tranon.2021.101133
Diehl, K. H. et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 21, 15–23 (2001).
pubmed: 11180276
doi: 10.1002/jat.727
Turner, P. V., Brabb, T., Pekow, C. & Vasbinder, M. A. Administration of substances to laboratory animals: routes of administration and factors to consider. J. Am. Assoc. Lab. Anim. Sci. 50, 600–613 (2011).
pubmed: 22330705
pmcid: 3189662
Glascock, J. J. et al. Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice. J. Vis. Exp. https://doi.org/10.3791/2968 (2011).
doi: 10.3791/2968
pubmed: 21988897
pmcid: 3227174
Blair-Handon, R., Mueller, K. & Hoogstraten-Miller, S. An alternative method for intrathymic injections in mice. Lab. Anim. 39, 248–252 (2010).
doi: 10.1038/laban0810-248
Okano, M. et al. Orthotopic implantation achieves better engraftment and faster growth than subcutaneous implantation in breast cancer patient-derived xenografts. J. Mammary Gland Biol. Neoplasia 25, 27–36 (2020).
pubmed: 32109311
pmcid: 7141774
doi: 10.1007/s10911-020-09442-7
Rashid, O. M. et al. An improved syngeneic orthotopic murine model of human breast cancer progression. Breast Cancer Res. Treat. 147, 501–512 (2014).
pubmed: 25200444
pmcid: 4176514
doi: 10.1007/s10549-014-3118-0
Zhang, G. L., Zhang, Y., Cao, K. X. & Wang, X. M. Orthotopic injection of breast cancer cells into the mice mammary fat pad. J. Vis. Exp. https://doi.org/10.3791/58604 (2019).
doi: 10.3791/58604
pubmed: 31929505
Byrne, A. T. et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat. Rev. Cancer 17, 254–268 (2017).
pubmed: 28104906
doi: 10.1038/nrc.2016.140
Tavera-Mendoza, L. E. & Brown, M. A less invasive method for orthotopic injection of breast cancer cells into the mouse mammary gland. Lab. Anim. 51, 85–88 (2017).
pubmed: 26994106
doi: 10.1177/0023677216640706
Katsuta, E. et al. Modified breast cancer model for preclinical immunotherapy studies. J. Surg. Res. 204, 467–474 (2016).
pubmed: 27565084
pmcid: 5002312
doi: 10.1016/j.jss.2016.06.003
Martinez-Sabadell, A., Ovejero Romero, P., Arribas, J. & Arenas, E. J. Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice. STAR Protoc. 3, 101712 (2022).
pubmed: 36317178
pmcid: 9617204
doi: 10.1016/j.xpro.2022.101712
Krause, S., Brock, A. & Ingber, D. E. Intraductal injection for localized drug delivery to the mouse mammary gland. J. Vis. Exp. https://doi.org/10.3791/50692 (2013).
doi: 10.3791/50692
pubmed: 24121742
pmcid: 3938324
Bu, W. & Li, Y. Intraductal injection of lentivirus vectors for stably introducing genes into rat mammary epithelial cells in vivo. J. Mammary Gland Biol. Neoplasia 25, 389–396 (2020).
pubmed: 33165800
pmcid: 7965254
doi: 10.1007/s10911-020-09469-w
Barahona, M. J., Rojas, J., Uribe, E. A. & Garcia-Robles, M. A. Tympanic membrane rupture during stereotaxic surgery disturbs the normal feeding behavior in rats. Front. Behav. Neurosci. 14, 591204 (2020).
pubmed: 33335480
pmcid: 7735996
Ferry, B. & Gervasoni, D. Improving stereotaxic neurosurgery techniques and procedures greatly reduces the number of rats used per experimental group—a practice report. Animals 11, 2662 (2021).
pubmed: 34573633
pmcid: 8465152
doi: 10.3390/ani11092662
Irtenkauf, S. M. et al. Optimization of glioblastoma mouse orthotopic xenograft models for translational research. Comp. Med. 67, 300–314 (2017).
pubmed: 28830577
pmcid: 5557202
Onn, A. et al. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin. Cancer Res. 9, 5532–5539 (2003).
pubmed: 14654533
Boehle, A. S., Dohrmann, P., Leuschner, I., Kalthoff, H. & Henne-Bruns, D. An improved orthotopic xenotransplant procedure for human lung cancer in SCID bg mice. Ann. Thorac. Surg. 69, 1010–1015 (2000).
pubmed: 10800785
doi: 10.1016/S0003-4975(00)01090-0
Kang, Y. et al. Development of an orthotopic transplantation model in nude mice that simulates the clinical features of human lung cancer. Cancer Sci. 97, 996–1001 (2006).
pubmed: 16984373
pmcid: 11158814
doi: 10.1111/j.1349-7006.2006.00276.x
Buckle, T. & van Leeuwen, F. W. Validation of intratracheal instillation of lung tumour cells in mice using single photon emission computed tomography/computed tomography imaging. Lab. Anim. 44, 40–45 (2010).
pubmed: 19854758
doi: 10.1258/la.2009.009030
Nakajima, T. et al. Orthotopic lung cancer murine model by nonoperative transbronchial approach. Ann. Thorac. Surg. 97, 1771–1775 (2014).
pubmed: 24792261
doi: 10.1016/j.athoracsur.2014.01.048
Das, S., MacDonald, K., Chang, H. Y. & Mitzner, W. A simple method of mouse lung intubation. J. Vis. Exp. 73, e50318 (2013).
Brown, R. H., Walters, D. M., Greenberg, R. S. & Mitzner, W. A method of endotracheal intubation and pulmonary functional assessment for repeated studies in mice. J. Appl. Physiol. 87, 2362–2365 (1999).
pubmed: 10601190
doi: 10.1152/jappl.1999.87.6.2362
Roughan, J. V., Bertrand, H. G. & Isles, H. M. Meloxicam prevents COX-2-mediated post-surgical inflammation but not pain following laparotomy in mice. Eur. J. Pain. 20, 231–240 (2016).
pubmed: 25908253
doi: 10.1002/ejp.712
Kashtan, H. et al. Intra-rectal injection of tumour cells: a novel animal model of rectal cancer. Surg. Oncol. 1, 251–256 (1992).
pubmed: 1341258
doi: 10.1016/0960-7404(92)90072-S
Richon, S., Zajac, O., Perez Gonzalez, C. & Matic Vignjevic, D. Optimized protocol for the generation of an orthotopic colon cancer mouse model and metastasis. STAR Protoc. 4, 102022 (2023).
pubmed: 36638019
pmcid: 9846123
doi: 10.1016/j.xpro.2022.102022
Zigmond, E. et al. Utilization of murine colonoscopy for orthotopic implantation of colorectal cancer. PLoS ONE 6, e28858 (2011).
pubmed: 22174916
pmcid: 3236220
doi: 10.1371/journal.pone.0028858
Hite, N. et al. An optimal orthotopic mouse model for human colorectal cancer primary tumor growth and spontaneous metastasis. Dis. Colon Rectum 61, 698–705 (2018).
pubmed: 29722728
doi: 10.1097/DCR.0000000000001096
McVeigh, L. E. et al. Development of orthotopic tumour models using ultrasound-guided intrahepatic injection. Sci. Rep. 9, 9904 (2019).
pubmed: 31289364
pmcid: 6616610
doi: 10.1038/s41598-019-46410-6
Huynh, A. S. et al. Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells. PLoS ONE 6, e20330 (2011).
pubmed: 21647423
pmcid: 3103544
doi: 10.1371/journal.pone.0020330
Camara Serrano, J. A. Ultrasound guided surgery as a refinement tool in oncology research. Animals 12, 3445 (2022).
pubmed: 36496966
pmcid: 9739685
doi: 10.3390/ani12233445
RA, V. A. N. N. et al. Tissue-directed implantation using ultrasound visualization for development of biologically relevant metastatic tumor xenografts. Vivo 31, 779–791 (2017).
Jager, W. et al. Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach. PLoS ONE 8, e59536 (2013).
pubmed: 23555699
pmcid: 3608695
doi: 10.1371/journal.pone.0059536
Hadaschik, B. A. et al. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging. BJU Int. 100, 1377–1384 (2007).
pubmed: 17850390
doi: 10.1111/j.1464-410X.2007.07165.x
Watanabe, T. et al. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies. Cancer Gene Ther. 7, 1575–1580 (2000).
pubmed: 11228536
doi: 10.1038/sj.cgt.7700261
Yardeni, T., Eckhaus, M., Morris, H. D., Huizing, M. & Hoogstraten-Miller, S. Retro-orbital injections in mice. Lab. Anim. 40, 155–160 (2011).
doi: 10.1038/laban0511-155
Leon-Rico, D. et al. Comparison of haematopoietic stem cell engraftment through the retro-orbital venous sinus and the lateral vein: alternative routes for bone marrow transplantation in mice. Lab. Anim. 49, 132–141 (2015).
pubmed: 25586937
doi: 10.1177/0023677214567915
Li, Q. et al. Analyses of very early hemopoietic regeneration after bone marrow transplantation: comparison of intravenous and intrabone marrow routes. Stem Cells 25, 1186–1194 (2007).
pubmed: 17322105
doi: 10.1634/stemcells.2006-0354
Kushida, T. et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 97, 3292–3299 (2001).
pubmed: 11342461
doi: 10.1182/blood.V97.10.3292
Sawyer, G. J. et al. Cardiovascular function following acute volume overload for hydrodynamic gene delivery to the liver. Gene Ther. 14, 1208–1217 (2007).
pubmed: 17568768
doi: 10.1038/sj.gt.3302976
Suda, T., Gao, X., Stolz, D. B. & Liu, D. Structural impact of hydrodynamic injection on mouse liver. Gene Ther. 14, 129–137 (2007).
pubmed: 16988719
doi: 10.1038/sj.gt.3302865
Campbell, J. P., Merkel, A. R., Masood-Campbell, S. K., Elefteriou, F. & Sterling, J. A. Models of bone metastasis. J. Vis. Exp. 4, e4260 (2012).
Zhou, H. & Zhao, D. Ultrasound imaging-guided intracardiac injection to develop a mouse model of breast cancer brain metastases followed by longitudinal MRI. J. Vis. Exp. https://doi.org/10.3791/51146 (2014).
doi: 10.3791/51146
pubmed: 25489842
pmcid: 4354438
Stocking, K. L. et al. Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of tumor cells. Comp. Med. 59, 37–45 (2009).
pubmed: 19295053
pmcid: 2703139
Gehling, A. M. et al. evaluation of volume of intramuscular injection into the caudal thigh muscles of female and male BALB/c mice (Mus musculus). J. Am. Assoc. Lab. Anim. Sci. 57, 35–43 (2018).
pubmed: 29402350
pmcid: 5875096
Pfeiffenberger, U. et al. Assessment and refinement of intra-bone marrow transplantation in mice. Lab. Anim. 49, 121–131 (2015).
pubmed: 25416608
doi: 10.1177/0023677214559627
Uluckan, O., Segaliny, A., Botter, S., Santiago, J. M. & Mutsaers, A. J. Preclinical mouse models of osteosarcoma. Bonekey Rep. 4, 670 (2015).
pubmed: 25987985
pmcid: 4422092
doi: 10.1038/bonekey.2015.37
Abel, E. L., Angel, J. M., Kiguchi, K. & DiGiovanni, J. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc. 4, 1350–1362 (2009).
pubmed: 19713956
pmcid: 3213400
doi: 10.1038/nprot.2009.120
Tolba, R., Kraus, T., Liedtke, C., Schwarz, M. & Weiskirchen, R. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice. Lab. Anim. 49, 59–69 (2015).
pubmed: 25835739
doi: 10.1177/0023677215570086
Zeng, L., Li, W. & Chen, C. S. Breast cancer animal models and applications. Zool. Res. 41, 477–494 (2020).
pubmed: 32629551
pmcid: 7475017
doi: 10.24272/j.issn.2095-8137.2020.095
Rivina, L., Davoren, M. J. & Schiestl, R. H. Mouse models for radiation-induced cancers. Mutagenesis 31, 491–509 (2016).
pubmed: 27209205
pmcid: 6280996
doi: 10.1093/mutage/gew019
Scholten, D., Trebicka, J., Liedtke, C. & Weiskirchen, R. The carbon tetrachloride model in mice. Lab. Anim. 49, 4–11 (2015).
pubmed: 25835733
doi: 10.1177/0023677215571192
Duran-Struuck, R. & Dysko, R. C. Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies. J. Am. Assoc. Lab. Anim. Sci. 48, 11–22 (2009).
pubmed: 19245745
pmcid: 2694700
Tang, B., Foss, K., Lichtor, T., Phillips, H. & Roy, E. Resection of orthotopic murine brain glioma. Neuroimmunol. Neuroinflamm. 8, 64–69 (2021).
Gast, C. E., Shaw, A. K., Wong, M. H. & Coussens, L. M. Surgical procedures and methodology for a preclinical murine model of de novo mammary cancer metastasis. J. Vis. Exp. https://doi.org/10.3791/54852 (2017).
doi: 10.3791/54852
pubmed: 28784976
pmcid: 5613781
Ren, L., Huang, S., Beck, J. & LeBlanc, A. K. Impact of limb amputation and cisplatin chemotherapy on metastatic progression in mouse models of osteosarcoma. Sci. Rep. 11, 24435 (2021).
pubmed: 34952927
pmcid: 8709858
doi: 10.1038/s41598-021-04018-9
Mallya, K., Gautam, S. K., Aithal, A., Batra, S. K. & Jain, M. Modeling pancreatic cancer in mice for experimental therapeutics. Biochim. Biophys. Acta Rev. Cancer 1876, 188554 (2021).
pubmed: 33945847
pmcid: 8570383
doi: 10.1016/j.bbcan.2021.188554
Linxweiler, J. et al. Primary tumor resection decelerates disease progression in an orthotopic mouse model of metastatic prostate cancer. Cancers 14, 737 (2022).
Sweeney, K. J. et al. Validation of an imageable surgical resection animal model of glioblastoma (GBM). J. Neurosci. Methods 233, 99–104 (2014).
pubmed: 24952322
doi: 10.1016/j.jneumeth.2014.05.006
Chuprin, J. et al. Humanized mouse models for immuno-oncology research. Nat. Rev. Clin. Oncol. 20, 192–206 (2023).
pubmed: 36635480
pmcid: 10593256
doi: 10.1038/s41571-022-00721-2
Deboer, M. D. Animal models of anorexia and cachexia. Expert Opin. Drug Discov. 4, 1145–1155 (2009).
pubmed: 20160874
pmcid: 2771941
doi: 10.1517/17460440903300842
Bennani-Baiti, N. & Walsh, D. Animal models of the cancer anorexia–cachexia syndrome. Support Care Cancer 19, 1451–1463 (2011).
pubmed: 20714754
doi: 10.1007/s00520-010-0972-0
Euhus, D. M., Hudd, C., LaRegina, M. C. & Johnson, F. E. Tumor measurement in the nude mouse. J. Surg. Oncol. 31, 229–234 (1986).
pubmed: 3724177
doi: 10.1002/jso.2930310402
Tomayko, M. M. & Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148–154 (1989).
pubmed: 2544306
doi: 10.1007/BF00300234
Ishida, K. et al. Current mouse models of oral squamous cell carcinoma: genetic and chemically induced models. Oral. Oncol. 73, 16–20 (2017).
pubmed: 28939069
doi: 10.1016/j.oraloncology.2017.07.028
Naik, K. et al. The histopathology of oral cancer pain in a mouse model and a human cohort. J. Dent. Res. 100, 194–200 (2021).
pubmed: 33030108
doi: 10.1177/0022034520961020
Pacharinsak, C. & Beitz, A. Animal models of cancer pain. Comp. Med. 58, 220–233 (2008).
pubmed: 18589864
pmcid: 2704117
Pineda-Farias, J. B., Saloman, J. L. & Scheff, N. N. Animal models of cancer-related pain: current perspectives in translation. Front. Pharmacol. 11, 610894 (2020).
pubmed: 33381048
pmcid: 7768910
doi: 10.3389/fphar.2020.610894
Tetreault, M. P. Esophageal cancer: insights from mouse models. Cancer Growth Metastasis 8, 37–46 (2015).
pubmed: 26380556
pmcid: 4558891
Cardesa, A., Ovelar, M. Y. & Pera, M. in Digestive System (eds Carlyle Jones, T., Popp, J. A. & Mohr, U.) 318–322 (Springer Berlin, 1997).
Hu, H. et al. Real-time bioluminescence and tomographic imaging of gastric cancer in a novel orthotopic mouse model. Oncol. Rep. 27, 1937–1943 (2012).
pubmed: 22407359
Hayakawa, Y. et al. Mouse models of gastric cancer. Cancers 5, 92–130 (2013).
pubmed: 24216700
pmcid: 3730302
doi: 10.3390/cancers5010092
Bhargava, S., Hotz, B., Buhr, H. J. & Hotz, H. G. An orthotopic nude mouse model for preclinical research of gastric cardia cancer. Int. J. Colorectal Dis. 24, 31–39 (2009).
pubmed: 18825389
doi: 10.1007/s00384-008-0584-z
Liu, S. et al. Dynamic observation of the progression of chronic gastritis to gastric cancer in a disease–TCM pattern rat model. J. Trad. Chin. Med. Sci. 8, 124–134 (2021).
Herreros-Villanueva, M., Hijona, E., Cosme, A. & Bujanda, L. Mouse models of pancreatic cancer. World J. Gastroenterol. 18, 1286–1294 (2012).
pubmed: 22493542
pmcid: 3319955
doi: 10.3748/wjg.v18.i12.1286
Lwin, T. M. et al. Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget 9, 37333–37342 (2018).
pubmed: 30647873
pmcid: 6324662
doi: 10.18632/oncotarget.26484
Becker, C. et al. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 54, 950–954 (2005).
pubmed: 15951540
pmcid: 1774595
doi: 10.1136/gut.2004.061283
Hasty, P. et al. eRapa restores a normal life span in a FAP mouse model. Cancer Prev. Res. 7, 169–178 (2014).
doi: 10.1158/1940-6207.CAPR-13-0299
Chartier, L. C., Hebart, M. L., Howarth, G. S., Whittaker, A. L. & Mashtoub, S. Affective state determination in a mouse model of colitis-associated colorectal cancer. PLoS ONE 15, e0228413 (2020).
pubmed: 31986185
pmcid: 6984705
doi: 10.1371/journal.pone.0228413
Ikenoue, T. et al. A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion. Sci. Rep. 6, 23899 (2016).
pubmed: 27032374
pmcid: 4817147
doi: 10.1038/srep23899
Vogt, A. et al. Alpha-fetoprotein- and CD40 ligand-expressing dendritic cells for immunotherapy of hepatocellular carcinoma. Cancers 13, 3375 (2021).
pubmed: 34282787
pmcid: 8269346
doi: 10.3390/cancers13133375
Chen, Z., Li, S., Han, L. & He, X. Optimized protocol for an inducible rat model of liver tumor with chronic hepatocellular injury, inflammation, fibrosis, and cirrhosis. STAR Protoc. 2, 100353 (2021).
pubmed: 33665633
pmcid: 7905469
doi: 10.1016/j.xpro.2021.100353
Odashima, S. Comparative studies on the transplantability of liver cancers induced in rats fed with 3′-methyl-4-dimethylaminoazobenzene for 3–6 months. Gan 53, 325–348 (1962).
pubmed: 13939454
Pretto, F. et al. Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle. Oncotarget 6, 3043–3054 (2015).
pubmed: 25460504
doi: 10.18632/oncotarget.2812
Roughan, J. V., Coulter, C. A., Flecknell, P. A., Thomas, H. D. & Sufka, K. J. The conditioned place preference test for assessing welfare consequences and potential refinements in a mouse bladder cancer model. PLoS ONE 9, e103362 (2014).
pubmed: 25100208
pmcid: 4123882
doi: 10.1371/journal.pone.0103362
Naito, T., Higuchi, T., Shimada, Y. & Kakinuma, C. An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer. Oncol. Lett. 19, 833–839 (2020).
pubmed: 31885717
Philyppov, I. B. et al. Alterations in detrusor contractility in rat model of bladder cancer. Sci. Rep. 10, 19651 (2020).
pubmed: 33184390
pmcid: 7665011
doi: 10.1038/s41598-020-76653-7
Xiao, Z. et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br. J. Cancer 81, 638––646 (1999).
pubmed: 10574249
pmcid: 2362887
doi: 10.1038/sj.bjc.6690741
Ding, J. et al. Current animal models of bladder cancer: awareness of translatability (review). Exp. Ther. Med. 8, 691–699 (2014).
pubmed: 25120584
pmcid: 4113637
doi: 10.3892/etm.2014.1837
Senapati, S. et al. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK–RhoA signaling pathway. Oncogene 29, 1293–1302 (2010).
pubmed: 19946339
doi: 10.1038/onc.2009.420
Pang, K. et al. Monitoring circulating prostate cancer cells by in vivo flow cytometry assesses androgen deprivation therapy on metastasis. Cytom. A 93, 517–524 (2018).
doi: 10.1002/cyto.a.23369
De Ciantis, P. D., Yashpal, K., Henry, J. & Singh, G. Characterization of a rat model of metastatic prostate cancer bone pain. J. Pain. Res. 3, 213–221 (2010).
pubmed: 21197325
pmcid: 3004636
Bosland, M. C., Schlicht, M. J., Horton, L. & McCormick, D. L. The MNU plus testosterone rat model of prostate carcinogenesis. Toxicol. Pathol. 50, 478–496 (2022).
pubmed: 35588266
pmcid: 9347216
doi: 10.1177/01926233221096345
Haldorsen, I. S. et al. Multimodal imaging of orthotopic mouse model of endometrial carcinoma. PLoS ONE 10, e0135220 (2015).
pubmed: 26252891
pmcid: 4529312
doi: 10.1371/journal.pone.0135220
Baert, T. et al. The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer. J. Immunother. Cancer 3, 57 (2015).
pubmed: 26676113
pmcid: 4678634
doi: 10.1186/s40425-015-0102-0
Rose, G. S. et al. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am. J. Obstet. Gynecol. 175, 593–599 (1996).
pubmed: 8828419
doi: 10.1053/ob.1996.v175.a73595
He, C. et al. A human papillomavirus-independent cervical cancer animal model reveals unconventional mechanisms of cervical carcinogenesis. Cell Rep. 26, 2636–2650 e2635 (2019).
pubmed: 30840887
pmcid: 6812687
doi: 10.1016/j.celrep.2019.02.004
Henkle, T. R. et al. Development of a novel mouse model of spontaneous high-risk hpve6/e7-expressing carcinoma in the cervicovaginal tract. Cancer Res. 81, 4560–4569 (2021).
pubmed: 34215618
pmcid: 8416934
doi: 10.1158/0008-5472.CAN-21-0399
Hamada, K., Ueda, N., Ito, M., Roth, J. A. & Follen, M. The nude rat as an orthotopic model for cervical cancer. Gynecol. Oncol. 99, S159–S165 (2005).
pubmed: 16185752
doi: 10.1016/j.ygyno.2005.07.073
Koutcher, J. A. et al. MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials. Neoplasia 4, 480–485 (2002).
pubmed: 12407441
pmcid: 1503661
doi: 10.1038/sj.neo.7900269
Bouckaert, C. et al. Development of a rat model for glioma-related epilepsy. Int. J. Mol. Sci. 21, 6999 (2020).
pubmed: 32977526
pmcid: 7582710
doi: 10.3390/ijms21196999
Nagarajan, P. P. et al. Lentiviral-induced spinal cord gliomas in rat model. Int. J. Mol. Sci. 22, 12943 (2021).
pubmed: 34884748
pmcid: 8657985
doi: 10.3390/ijms222312943
Shimoyama, M., Tanaka, K., Hasue, F. & Shimoyama, N. A mouse model of neuropathic cancer pain. Pain 99, 167–174 (2002).
pubmed: 12237194
doi: 10.1016/S0304-3959(02)00073-8
Mao-Ying, Q.-L. et al. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem. Biophys. Res. Commun. 345, 1292–1298 (2006).
pubmed: 16725112
doi: 10.1016/j.bbrc.2006.04.186
Yang, H. et al. Proteomic analysis of spinal cord tissue in a rat model of cancer-induced bone pain. Front. Mol. Neurosci. 15, 1009615 (2022).
pubmed: 36545122
pmcid: 9760935
doi: 10.3389/fnmol.2022.1009615
Gelbard, A. et al. An orthotopic murine model of sinonasal malignancy. Clin. Cancer Res. 14, 7348–7357 (2008).
pubmed: 19010850
pmcid: 5428892
doi: 10.1158/1078-0432.CCR-08-0977
Feron, V. J., Woutersen, R. A., van Garderen-Hoetmer, A. & Dreef-van der Meulen, H. C. Upper respiratory tract tumors in Cpb:WU (Wistar random) rats. Environ. Health Perspect. 85, 305–315 (1990).
pubmed: 2384064
pmcid: 1568344
Miller, A. L. & Roughan, J. V. Welfare assessment, end-point refinement and the effects of non-aversive handling in C57BL/6 mice with Lewis lung cancer. Animals https://doi.org/10.3390/ani12010023 (2021).
Mendoza, A. et al. A novel noninvasive method for evaluating experimental lung metastasis in mice. J. Am. Assoc. Lab. Anim. Sci. 52, 584–589 (2013).
pubmed: 24041215
pmcid: 3784665
Byhardt, R. W., Almagro, U. A., Fish, B. L. & Moulder, J. E. Development of a rat lung cancer model. Int. J. Radiat. Oncol. Biol. Phys. 10, 2125–2130 (1984).
pubmed: 6490438
doi: 10.1016/0360-3016(84)90212-8
Zhu, X. C. et al. Analgesic effects of lappaconitine in leukemia bone pain in a mouse model. PeerJ 3, e936 (2015).
pubmed: 26019998
pmcid: 4435501
doi: 10.7717/peerj.936
Helseth, A., Siegal, G. P., Haug, E. & Bautch, V. L. Transgenic mice that develop pituitary tumors. a model for Cushing’s disease. Am. J. Pathol. 140, 1071–1080 (1992).
pubmed: 1316082
pmcid: 1886503
Chang-Wei, H., Li, Y. B., Han, X. Y., Yin, G. F. & Wang, X. R. To explore the change of motor cognitive function in pituitary tumor rats after operation. Comput. Assist. Surg. 28, 2198099 (2023).
doi: 10.1080/24699322.2023.2198099
Kim, W. G., Park, J. W., Willingham, M. C. & Cheng, S. Y. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model. Endocrinology 154, 2936–2947 (2013).
pubmed: 23748362
pmcid: 3713208
doi: 10.1210/en.2013-1128
Snarskaya, E. S., Pylev, L. N., Akhunzyanov, A. A. & Kuznetсova, E. V. Experimental basosquamous carcinoma model in rats. BioNanoScience 7, 423–427 (2017).
doi: 10.1007/s12668-016-0380-0
Stribbling, S. M. & Ryan, A. J. The cell-line-derived subcutaneous tumor model in preclinical cancer research. Nat. Protoc. 17, 2108–2128 (2022).
pubmed: 35859135
doi: 10.1038/s41596-022-00709-3
Ehx, G. et al. Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice. Front. Immunol. 9, 1943 (2018).
pubmed: 30214443
pmcid: 6125392
doi: 10.3389/fimmu.2018.01943
Lai, H. Y., Chou, T. Y., Tzeng, C. H. & Lee, O. K. Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation. Cell Transplant. 21, 2033–2045 (2012).
pubmed: 22840591
doi: 10.3727/096368912X653110
Ullman-Cullere, M. H. & Foltz, C. J. Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab. Anim. Sci. 49, 319–323 (1999).
pubmed: 10403450
Hickman, D. L. & Swan, M. Use of a body condition score technique to assess health status in a rat model of polycystic kidney disease. J. Am. Assoc. Lab. Anim. Sci. 49, 155–159 (2010).
pubmed: 20353688
pmcid: 2846001
Burkholder, T., Foltz, C., Karlsson, E., Linton, C. G. & Smith, J. M. Health evaluation of experimental laboratory mice. Curr. Protoc. Mouse Biol. 2, 145–165 (2012).
pubmed: 22822473
pmcid: 3399545
doi: 10.1002/9780470942390.mo110217
Raja, S. N. et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain 161, 1976–1982 (2020).
pubmed: 32694387
pmcid: 7680716
doi: 10.1097/j.pain.0000000000001939
Langford, D. J. et al. Coding of facial expressions of pain in the laboratory mouse. Nat. Methods 7, 447–449 (2010).
pubmed: 20453868
doi: 10.1038/nmeth.1455
Sotocinal, S. G. et al. The Rat Grimace scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions. Mol. Pain. 7, 55 (2011).
pubmed: 21801409
pmcid: 3163602
Jirkof, P. et al. Assessment of postsurgical distress and pain in laboratory mice by nest complexity scoring. Lab. Anim. 47, 153–161 (2013).
pubmed: 23563122
doi: 10.1177/0023677213475603
Jirkof, P. et al. Burrowing behavior as an indicator of post-laparotomy pain in mice. Front. Behav. Neurosci. 4, 165 (2010).
pubmed: 21031028
pmcid: 2965018
doi: 10.3389/fnbeh.2010.00165
Turner, P. V., Pang, D. S. & Lofgren, J. L. A review of pain assessment methods in laboratory rodents. Comp. Med. 69, 451–467 (2019).
pubmed: 31896391
pmcid: 6935698
doi: 10.30802/AALAS-CM-19-000042
Deuis, J. R., Dvorakova, L. S. & Vetter, I. Methods used to evaluate pain behaviors in rodents. Front. Mol. Neurosci. 10, 284 (2017).
pubmed: 28932184
pmcid: 5592204
doi: 10.3389/fnmol.2017.00284
Wright-Williams, S. L., Courade, J. P., Richardson, C. A., Roughan, J. V. & Flecknell, P. A. Effects of vasectomy surgery and meloxicam treatment on faecal corticosterone levels and behaviour in two strains of laboratory mouse. Pain 130, 108–118 (2007).
pubmed: 17196337
doi: 10.1016/j.pain.2006.11.003
Do, J. P. et al. Automated and continuous monitoring of animal welfare through digital alerting. Comp. Med. 70, 313–327 (2020).
pubmed: 32414427
pmcid: 7446638
doi: 10.30802/AALAS-CM-19-000090
Collins, D. E., Mulka, K. R., Hoenerhoff, M. J., Taichman, R. S. & Villano, J. S. Clinical assessment of urinary tract damage during sustained-release estrogen supplementation in mice. Comp. Med. 67, 11–21 (2017).
pubmed: 28222835
pmcid: 5310620
Pearse, G., Frith, J., Randall, K. J. & Klinowska, T. Urinary retention and cystitis associated with subcutaneous estradiol pellets in female nude mice. Toxicol. Pathol. 37, 227–234 (2009).
pubmed: 19181629
doi: 10.1177/0192623308329281
Guyenet, S. J. et al. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J. Vis. Exp. https://doi.org/10.3791/1787 (2010).
doi: 10.3791/1787
pubmed: 20495529
pmcid: 3121238
Gao, X. et al. in Brain Tumors Vol. 158 (ed. Seano, G.) 199–220 (Springer, 2021).
Kelp, A. et al. A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers. J. Neurosci. 33, 9068–9081 (2013).
pubmed: 23699518
pmcid: 6705027
doi: 10.1523/JNEUROSCI.5622-12.2013
Bieler, L. et al. Motor deficits following dorsal corticospinal tract transection in rats: voluntary versus skilled locomotion readouts. Heliyon 4, e00540 (2018).
pubmed: 29560455
pmcid: 5857638
doi: 10.1016/j.heliyon.2018.e00540
Brough, D. W., Murkin, J. T., Amos, H. E., Smith, A. I. & Turley, K. D. Comparing variability in measurement of subcutaneous tumors in mice using 3D thermal imaging and calipers. Comp. Med. 72, 364–375 (2022).
pubmed: 36744510
pmcid: 9827613
doi: 10.30802/AALAS-CM-22-000033
Jensen, M. M., Jorgensen, J. T., Binderup, T. & Kjaer, A. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG–microPET or external caliper. BMC Med. Imaging 8, 16 (2008).
pubmed: 18925932
pmcid: 2575188
doi: 10.1186/1471-2342-8-16
Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A. A. & Gutkind, J. S. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer Prev. Res. 2, 27–36 (2009).
doi: 10.1158/1940-6207.CAPR-08-0147
Tanaka, T., Kojima, T., Okumura, A., Yoshimi, N. & Mori, H. Alterations of the nucleolar organizer regions during 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats. Carcinogenesis 12, 329–333 (1991).
pubmed: 1704823
doi: 10.1093/carcin/12.2.329
Goetze, R. G. et al. Utilizing high resolution ultrasound to monitor tumor onset and growth in genetically engineered pancreatic cancer models. J. Vis. Exp. https://doi.org/10.3791/56979 (2018).
doi: 10.3791/56979
pubmed: 29683461
pmcid: 5933419
Glaser, G. et al. Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft. PLoS ONE 10, e0126867 (2015).
pubmed: 25962155
pmcid: 4427104
doi: 10.1371/journal.pone.0126867
Vitetta, E. S. et al. Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established. Blood 89, 4425–4436 (1997).
pubmed: 9192767
doi: 10.1182/blood.V89.12.4425
Bruckner, M. et al. Murine endoscopy for in vivo multimodal imaging of carcinogenesis and assessment of intestinal wound healing and inflammation. J. Vis. Exp. https://doi.org/10.3791/51875 (2014).
doi: 10.3791/51875
pubmed: 25226434
pmcid: 4828016
Kodani, T. et al. Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system. J. Vis. Exp. 80, e50843 (2013).
Habibollahi, P. et al. Optical Imaging with a cathepsin B activated probe for the enhanced detection of esophageal adenocarcinoma by dual channel fluorescent upper GI endoscopy. Theranostics 2, 227–234 (2012).
pubmed: 22400064
pmcid: 3296470
doi: 10.7150/thno.4088
Dassie, E. et al. Detection of fluorescent organic nanoparticles by confocal laser endomicroscopy in a rat model of Barrett’s esophageal adenocarcinoma. Int. J. Nanomed. 10, 6811–6823 (2015).
doi: 10.2147/IJN.S86640
Wong, G. S. et al. Optical imaging of periostin enables early endoscopic detection and characterization of esophageal cancer in mice. Gastroenterology 144, 294–297 (2013).
pubmed: 23085486
doi: 10.1053/j.gastro.2012.10.030
El-Masry, O. S. et al. Oral intragastric DMBA administration induces acute lymphocytic leukemia and other tumors in male Wistar rats. J. Exp. Pharmacol. 14, 87–96 (2022).
pubmed: 35241938
pmcid: 8887968
doi: 10.2147/JEP.S349047
Tannous, B. A. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat. Protoc. 4, 582–591 (2009).
pubmed: 19373229
pmcid: 2692611
doi: 10.1038/nprot.2009.28
Delgado-SanMartin, J. et al. An innovative non-invasive technique for subcutaneous tumour measurements. PLoS ONE 14, e0216690 (2019).
pubmed: 31609977
pmcid: 6791540
doi: 10.1371/journal.pone.0216690
Klerk, C. P. et al. Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques 43, 7–13, 30 (2007).
pubmed: 17936938
doi: 10.2144/000112515
Miller, I. S. et al. Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents. Sci. Rep. 9, 9204 (2019).
pubmed: 31235775
pmcid: 6591410
doi: 10.1038/s41598-019-45444-0
Jarzabek, M. A. et al. Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary. Drug Discov. Today 18, 1052–1066 (2013).
pubmed: 23792334
doi: 10.1016/j.drudis.2013.06.004
Zeamari, S., Rumping, G., Floot, B., Lyons, S. & Stewart, F. A. In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats. Br. J. Cancer 90, 1259–1264 (2004).
pubmed: 15026810
pmcid: 2409642
doi: 10.1038/sj.bjc.6601637
Netufo, O. et al. Refining glioblastoma surgery through the use of intra-operative fluorescence imaging agents. Pharmaceuticals 15, 550 (2022).
pubmed: 35631376
pmcid: 9143023
doi: 10.3390/ph15050550
Christensen, J., Vonwil, D. & Shastri, V. P. Non-invasive in vivo imaging and quantification of tumor growth and metastasis in rats using cells expressing far-red fluorescence protein. PLoS ONE 10, e0132725 (2015).
pubmed: 26186005
pmcid: 4505884
doi: 10.1371/journal.pone.0132725
Yang, N. et al. A novel GFP nude rat model to investigate tumor-stroma interactions. Cancer Cell Int. 14, 541 (2014).
pubmed: 25663822
pmcid: 4319225
doi: 10.1186/s12935-014-0146-0
Hoffman, R. M. Application of GFP imaging in cancer. Lab. Invest. 95, 432–452 (2015).
pubmed: 25686095
pmcid: 4383682
doi: 10.1038/labinvest.2014.154
Marien, E., Hillen, A., Vanderhoydonc, F., Swinnen, J. V. & Vande Velde, G. Longitudinal microcomputed tomography-derived biomarkers for lung metastasis detection in a syngeneic mouse model: added value to bioluminescence imaging. Lab. Invest. 97, 24–33 (2017).
pubmed: 27869796
doi: 10.1038/labinvest.2016.114
Nota, T. et al. Safety and feasibility of contrast-enhanced computed tomography with a nanoparticle contrast agent for evaluation of diethylnitrosamine-induced liver tumors in a rat model. Acad. Radiol. 30, 30–39 (2023).
pubmed: 35680546
doi: 10.1016/j.acra.2022.03.027
Olson, J. D. et al. A gated-7T MRI technique for tracking lung tumor development and progression in mice after exposure to low doses of ionizing radiation. Radiat. Res. 178, 321–327 (2012).
pubmed: 22950352
pmcid: 3478889
doi: 10.1667/RR2800.1
Baier, J. et al. Influence of MRI examinations on animal welfare and study results. Invest. Radiol. 55, 507–514 (2020).
pubmed: 32224718
doi: 10.1097/RLI.0000000000000669
Song, H. T. et al. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation. J. Transl. Med. 7, 88 (2009).
pubmed: 19840404
pmcid: 2774309
doi: 10.1186/1479-5876-7-88
Gui, Q. et al. A new rat model of bone cancer pain produced by rat breast cancer cells implantation of the shaft of femur at the third trochanter level. Cancer Biol. Ther. 14, 193–199 (2013).
pubmed: 23254954
pmcid: 3572001
doi: 10.4161/cbt.23291
Ayers, G. D. et al. Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. J. Ultrasound Med. 29, 891–901 (2010).
pubmed: 20498463
pmcid: 2925269
doi: 10.7863/jum.2010.29.6.891
Ghaddar, N. et al. Detection of lung tumor progression in mice by ultrasound imaging. J. Vis. Exp. https://doi.org/10.3791/60565 (2020).
doi: 10.3791/60565
pubmed: 32176201
Chen, J. Y. et al. Application of high-frequency ultrasound for the detection of surgical anatomy in the rodent abdomen. Vet. J. 191, 246–252 (2012).
pubmed: 21295505
doi: 10.1016/j.tvjl.2010.12.024
O’Farrell, A. C. et al. Implementing systems modelling and molecular imaging to predict the efficacy of BCL-2 inhibition in colorectal cancer patient-derived xenograft models. Cancers 12, 2978 (2020).
pubmed: 33066609
pmcid: 7602510
doi: 10.3390/cancers12102978
Sun, R. et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 19, 1180–1191 (2018).
pubmed: 30120041
doi: 10.1016/S1470-2045(18)30413-3
Aubry, K. et al. FDG-PET/CT of head and neck squamous cell carcinoma in a rat model. Mol. Imaging Biol. 11, 88–93 (2009).
pubmed: 19034583
doi: 10.1007/s11307-008-0183-y
Lofgren, J. et al. Analgesics promote welfare and sustain tumour growth in orthotopic 4T1 and B16 mouse cancer models. Lab. Anim. 52, 351–364 (2018).
pubmed: 29207902
doi: 10.1177/0023677217739934
Husmann, K. et al. Primary tumour growth in an orthotopic osteosarcoma mouse model is not influenced by analgesic treatment with buprenorphine and meloxicam. Lab. Anim. 49, 284–293 (2015).
pubmed: 25650386
doi: 10.1177/0023677215570989
Taylor, D. K. Influence of pain and analgesia on cancer research studies. Comp. Med. 69, 501–509 (2019).
pubmed: 31315692
pmcid: 6935705
doi: 10.30802/AALAS-CM-19-000002
Strohal, R. et al. Wound management with enzyme alginogels: expert consensus. Hautarzt 68, 36–42 (2017).
pubmed: 27680011
doi: 10.1007/s00105-016-3878-z
Chaudhary, A., Bag, S., Banerjee, P. & Chatterjee, J. Wound healing efficacy of Jamun honey in diabetic mice model through reepithelialization, collagen deposition and angiogenesis. J. Tradit. Complement. Med. 10, 529–543 (2020).
pubmed: 33134129
doi: 10.1016/j.jtcme.2019.10.002
Mitchell, C. M., Salyards, G. W., Theriault, B. R., Langan, G. P. & Luchins, K. R. Evaluation of pain and distress and therapeutic interventions for rectal prolapse in mice to reduce early study removal. J. Am. Assoc. Lab. Anim. Sci. 60, 692–699 (2021).
pubmed: 34749842
pmcid: 8628532
doi: 10.30802/AALAS-JAALAS-21-000038
Levin-Allerhand, J. A., Sokol, K. & Smith, J. D. Safe and effective method for chronic 17beta-estradiol administration to mice. Contemp. Top. Lab. Anim. Sci. 42, 33–35 (2003).
pubmed: 14615958
Fish, R., Danneman, P. J., Brown, M. & Karas, A. Anesthesia and Analgesia in Laboratory Animals (Academic Press, 2011).
Flecknell, P. Laboratory Animal Anaesthesia (Academic Press, 2015).
Foley, P. L., Kendall, L. V. & Turner, P. V. Clinical management of pain in rodents. Comp. Med. 69, 468–489 (2019).
pubmed: 31822323
pmcid: 6935704
doi: 10.30802/AALAS-CM-19-000048